|
1
|
Lv C, Hong Y, Miao L, Li C, Xu G, Wei S,
Wang B, Huang C and Jiao B: Wentilactone A as a novel potential
antitumor agent induces apoptosis and G2/M arrest of human lung
carcinoma cells, and is mediated by HRas-GTP accumulation to
excessively activate the Ras/Raf/ERK/p53-p21 pathway. Cell Death
Dis. 4:e9522013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Neal JW, Gubens MA and Wakelee HA: Current
management of small cell lung cancer. Clin Chest Med. 32:853–863.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mamdani H, Induru R and Jalal SI: Novel
therapies in small cell lung cancer. Transl Lung Cancer Res.
4:533–544. 2015.PubMed/NCBI
|
|
4
|
Hsieh TC and Wu JM: Resveratrol:
Biological and pharmaceutical properties as anticancer molecule.
Biofactors. 36:360–369. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kalantari H and Das DK: Physiological
effects of resveratrol. Biofactors. 36:401–406. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schnekenburger M, Dicato M and Diederich
M: Plant-derived epigenetic modulators for cancer treatment and
prevention. Biotechnol Adv. 32:1123–1132. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chan S, Kantham S, Rao VM, Palanivelu MK,
Pham HL, Shaw PN, McGeary RP and Ross BP: Metal chelation, radical
scavenging and inhibition of Aβ42 fibrillation by food constituents
in relation to Alzheimer’s disease. Food Chem. 199:185–194. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Blanquer-Rosselló MD, Hernández-López R,
Roca P, Oliver J and Valle A: Resveratrol induces mitochondrial
respiration and apoptosis in SW620 colon cancer cells. Biochim
Biophys Acta. 1861:431–440. 2017. View Article : Google Scholar
|
|
9
|
Shakibaei M, Harikumar KB and Aggarwal BB:
Resveratrol addiction: To die or not to die. Mol Nutr Food Res.
53:115–128. 2009. View Article : Google Scholar
|
|
10
|
Kundu JK and Surh YJ: Cancer
chemopreventive and therapeutic potential of resveratrol:
Mechanistic perspectives. Cancer Lett. 269:243–261. 2008.
View Article : Google Scholar
|
|
11
|
Athar M, Back JH, Kopelovich L, Bickers DR
and Kim AL: Multiple molecular targets of resveratrol:
Anti-carcinogenic mechanisms. Arch Biochem Biophys. 486:95–102.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Goswami SK and Das DK: Resveratrol and
chemoprevention. Cancer Lett. 284:1–6. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Delmas D, Lançon A, Colin D, Jannin B and
Latruffe N: Resveratrol as a chemopreventive agent: A promising
molecule for fighting cancer. Curr Drug Targets. 7:423–442. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bhardwaj A, Sethi G, Vadhan-Raj S,
Bueso-Ramos C, Takada Y, Gaur U, Nair AS, Shishodia S and Aggarwal
BB: Resveratrol inhibits proliferation, induces apoptosis, and
overcomes chemoresistance through down-regulation of STAT3 and
nuclear factor-kappaB-regulated antiapoptotic and cell survival
gene products in human multiple myeloma cells. Blood.
109:2293–2302. 2007. View Article : Google Scholar
|
|
15
|
Zhou HB, Chen JJ, Wang WX, Cai JT and Du
Q: Anticancer activity of resveratrol on implanted human primary
gastric carcinoma cells in nude mice. World J Gastroenterol.
11:280–284. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fuggetta MP, Lanzilli G, Tricarico M,
Cottarelli A, Falchetti R, Ravagnan G and Bonmassar E: Effect of
resveratrol on proliferation and telomerase activity of human colon
cancer cells in vitro. J Exp Clin Cancer Res. 25:189–193.
2006.PubMed/NCBI
|
|
17
|
Green DR, Galluzzi L and Kroemer G: Cell
biology. Metabolic control of cell death. Science. 345:12502562014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ma L, Li W, Wang R, Nan Y, Wang Q, Liu W
and Jin F: Resveratrol enhanced anticancer effects of cisplatin on
non-small cell lung cancer cell lines by inducing mitochondrial
dysfunction and cell apoptosis. Int J Oncol. 47:1460–1468. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Aggarwal BB, Bhardwaj A, Aggarwal RS,
Seeram NP, Shishodia S and Takada Y: Role of resveratrol in
prevention and therapy of cancer: Preclinical and clinical studies.
Anticancer Res. 24A:2783–2840. 2004.
|
|
20
|
Donnelly LE, Newton R, Kennedy GE, Fenwick
PS, Leung RH, Ito K, Russell RE and Barnes PJ: Anti-inflammatory
effects of resveratrol in lung epithelial cells: Molecular
mechanisms. Am J Physiol Lung Cell Mol Physiol. 287:L774–L783.
2004. View Article : Google Scholar
|
|
21
|
Surh YJ: Cancer chemoprevention with
dietary phytochemicals. Nat Rev Cancer. 3:768–780. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jang M, Cai L, Udeani GO, Slowing KV,
Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta
RG, et al: Cancer chemopreventive activity of resveratrol, a
natural product derived from grapes. Science. 275:218–220. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Baur JA and Sinclair DA: Therapeutic
potential of resveratrol: The in vivo evidence. Nat Rev Drug
Discov. 5:493–506. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
de la Lastra CA and Villegas I:
Resveratrol as an anti-inflammatory and anti-aging agent:
Mechanisms and clinical implications. Mol Nutr Food Res.
49:405–430. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Frampton GA, Lazcano EA, Li H, Mohamad A
and DeMorrow S: Resveratrol enhances the sensitivity of
cholangiocarcinoma to chemotherapeutic agents. Lab Invest.
90:1325–1338. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liou GY and Storz P: Reactive oxygen
species in cancer. Free Radic Res. 44:479–496. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zamzami N, Marchetti P, Castedo M,
Decaudin D, Macho A, Hirsch T, Susin SA, Petit PX, Mignotte B and
Kroemer G: Sequential reduction of mitochondrial transmembrane
potential and generation of reactive oxygen species in early
programmed cell death. J Exp Med. 182:367–377. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Polster BM and Fiskum G: Mitochondrial
mechanisms of neural cell apoptosis. J Neurochem. 90:1281–1289.
2004. View Article : Google Scholar
|
|
29
|
Cregan SP, Dawson VL and Slack RS: Role of
AIF in caspase-dependent and caspase-independent cell death.
Oncogene. 23:2785–2796. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Samarghandian S, Nezhad MA and Mohammadi
G: Role of caspases, Bax and Bcl-2 in chrysin-induced apoptosis in
the A549 human lung adenocarcinoma epithelial cells. Anticancer
Agents Med Chem. 14:901–909. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen D, Zheng X, Kang D, Yan B, Liu X, Gao
Y and Zhang K: Apoptosis and expression of the Bcl-2 family of
proteins and P53 in human pancreatic ductal adenocarcinoma. Med
Princ Pract. 21:68–73. 2012. View Article : Google Scholar
|
|
32
|
Chu SH, Lim JW, Kim DG, Lee ES, Kim KH and
Kim H: Down-regulation of Bcl-2 is mediated by NF-κB activation in
Helicobacter pylori-induced apoptosis of gastric epithelial cells.
Scand J Gastroenterol. 46:148–155. 2011. View Article : Google Scholar
|
|
33
|
Sun J, Li ZM, Hu ZY, Lin XB, Zhou NN, Xian
LJ, Yang DJ and Jiang WQ: ApoG2 inhibits antiapoptotic Bcl-2 family
proteins and induces mitochondria-dependent apoptosis in human
lymphoma U937 cells. Anticancer Drugs. 19:967–974. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kang CD, Jang JH, Kim KW, Lee HJ, Jeong
CS, Kim CM, Kim SH and Chung BS: Activation of c-jun N-terminal
kinase/ stress-activated protein kinase and the decreased ratio of
Bcl-2 to Bax are associated with the auto-oxidized dopamine-induced
apoptosis in PC12 cells. Neurosci Lett. 256:37–40. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang W, Guo Q, You Q, Zhang K, Yang Y, Yu
J, Liu W, Zhao L, Gu H, Hu Y, et al: Involvement of bax/bcl-2 in
wogonin-induced apoptosis of human hepatoma cell line SMMC-7721.
Anticancer Drugs. 17:797–805. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang B, Johnson TS, Thomas GL, Watson PF,
Wagner B, Furness PN and El Nahas AM: A shift in the Bax/Bcl-2
balance may activate caspase-3 and modulate apoptosis in
experimental glomerulonephritis. Kidney Int. 62:1301–1313. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
van Ginkel PR, Sareen D, Subramanian L,
Walker Q, Darjatmoko SR, Lindstrom MJ, Kulkarni A, Albert DM and
Polans AS: Resveratrol inhibits tumor growth of human neuroblastoma
and mediates apoptosis by directly targeting mitochondria. Clin
Cancer Res. 13:5162–5169. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pozo-Guisado E, Merino JM, Mulero-Navarro
S, Lorenzo-Benayas MJ, Centeno F, Alvarez-Barrientos A and
Fernandez-Salguero PM: Resveratrol-induced apoptosis in MCF-7 human
breast cancer cells involves a caspase-independent mechanism with
downregulation of Bcl-2 and NF-kappaB. Int J Cancer. 115:74–84.
2005. View Article : Google Scholar : PubMed/NCBI
|
